Mechanisms of hemagglutinin targeted influenza virus neutralization

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Brandenburg, Boerries ^a   Koudstaal, Wouter ^a   Goudsmit, Jaap ^a   Klaren, Vincent ^a   Tang, Chan ^a   Bujny, Miriam V ^a   Korse, Hans J W M ^a   Kwaks, Ted ^a   Otterstrom, Jason J ^b,c   Juraszek, Jarek ^a   Van Oijen, Antoine M ^b   Vogels, Ronald ^a   Friesen, Robert H E ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Building C 2   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY 8057; ANTIBODY 9114; ANTIBODY CR11054; ANTIBODY CR11055; ANTIBODY CR6261; ANTIBODY CR8020; ANTIBODY CR8033; ANTIBODY CR8071; ANTIBODY CR9020; ANTIBODY CR9114; ANTIBODY F10; ANTIBODY F16; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; INFLUENZA VIRUS; INTERNALIZATION; MEMBRANE FUSION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; VIRUS ATTACHMENT; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; HEMAGGLUTININS; HUMANS; IMMUNOBLOTTING; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84892615764     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080034     Document Type: Article

References (40)

1. Burton DR, Poignard P, Stanfield RL, Wilson IA (2012) Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337: 183-186.
2. Gerhard W (2001) The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol 260: 171-190.
3. Bertram S, Glowacka I, Steffen I, Kuhl A, Pohlmann S (2010) Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol 20: 298-310.
4. Gamblin SJ, Skehel JJ (2010) Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285: 28403-28409.
5. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, et al. (2008) Heterosubtypic neutralizingmonoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3: e3942.
6. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251.
7. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
8. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333: 843-850.
9. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333: 850-856.
10. Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, et al. (2012) Highly conserved protective epitopes on influenza B viruses. Science 337: 1343-1348.
11. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, et al. (2011) Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 108: 14216-14221.
12. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, et al. (2011) A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol 85: 10905-10908.
13. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, et al. (2012) Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489: 526-532.
14. Friesen RH, Koudstaal W, Koldijk MH, Weverling GJ, Brakenhoff JP, et al. (2010) New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS One 5: e9106.
15. Koudstaal W, Koldijk MH, Brakenhoff JP, Cornelissen LA, Weverling GJ, et al. (2009) Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir. J Infect Dis 200: 1870-1873.
16. Ekiert DC, Wilson IA (2012) Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2: 134-141.
17. Julien JP, Lee PS, Wilson IA (2012) Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA. Immunol Rev 250: 180-198.
18. Nabel GJ, Fauci AS (2010) Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine. Nat Med 16: 1389-1391.
19. Reading SA, Dimmock NJ (2007) Neutralization of animal virus infectivity by antibody. Arch Virol 152: 1047-1059.
20. Han T, Marasco WA (2011) Structural basis of influenza virus neutralization. Ann N Y Acad Sci 1217: 178-190.
21. Corti D, Lanzavecchia A (2013) Broadly neutralizing antiviral antibodies. Annu Rev Immunol 31: 705-742.
22. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552-2558.
23. Brandenburg B, Zhuang X (2007) Virus trafficking - learning from single-virus tracking. Nat Rev Microbiol 5: 197-208.
24. Floyd DL, Harrison SC, van Oijen AM (2009) Method for measurement of viral fusion kinetics at the single particle level. J Vis Exp 31: e1484.
25. Floyd DL, Ragains JR, Skehel JJ, Harrison SC, van Oijen AM (2008) Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci U S A 105: 15382-15387.
26. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, et al. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80: 9896-9898.
27. Bottcher-Friebertshauser E, Stein DA, Klenk HD, Garten W(2011) Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. J Virol 85: 1554-1562.
28. Burton DR (2002) Antibodies, viruses and vaccines. Nat Rev Immunol 2: 706-713.
29. Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6: 231-243.
30. Thomson CA, Wang Y, Jackson LM, Olson M, Wang W, et al. (2012) Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol 3: 87.
31. Rigg RJ, Carver AS, Dimmock NJ (1989) IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo. J Gen Virol 70 (Pt 8): 2097-2109.
32. Edwards MJ, Dimmock NJ (2000) Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition. Virology 278: 423-435.
33. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, et al. (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455: 532-536.
34. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, et al. (2002) An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294: 70-74.
35. Jones D, Kroos N, Anema R, van Montfort B, Vooys A, et al. (2003) High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19: 163-168.
36. Sanders BP, Edo-Matas D, Custers JH, Koldijk MH, Klaren V, et al. (2013) PER.C6((R)) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine. Vaccine 31: 850-856.
37. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
38. Vaughan JC, Brandenburg B, Hogle JM, Zhuang X (2009) Rapid actin-dependent viral motility in live cells. Biophys J 97: 1647-1656.
39. Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213-232.
40. Findlay JW, Dillard RF (2007) Appropriate calibration curve fitting in ligand binding assays. Aaps J 9: E260-267.